• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association of SARS-CoV-2 Genomic Load with Outcomes in Patients with COVID-19.

作者信息

Zacharioudakis Ioannis M, Prasad Prithiv J, Zervou Fainareti N, Basu Atreyee, Inglima Kenneth, Weisenberg Scott A, Aguero-Rosenfeld Maria E

机构信息

New York University Grossman School of Medicine New York, New York.

出版信息

Ann Am Thorac Soc. 2021 May;18(5):900-903. doi: 10.1513/AnnalsATS.202008-931RL.

DOI:10.1513/AnnalsATS.202008-931RL
PMID:33119425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8086542/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cde/8086542/13213a205b1a/AnnalsATS.202008-931RLf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cde/8086542/13213a205b1a/AnnalsATS.202008-931RLf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cde/8086542/13213a205b1a/AnnalsATS.202008-931RLf1.jpg

相似文献

1
Association of SARS-CoV-2 Genomic Load with Outcomes in Patients with COVID-19.严重急性呼吸综合征冠状病毒2基因组载量与新型冠状病毒肺炎患者预后的关联
Ann Am Thorac Soc. 2021 May;18(5):900-903. doi: 10.1513/AnnalsATS.202008-931RL.
2
Hospital laboratory experience with SARS-CoV-2 (COVID-19) molecular assay sample pooling method in New York City.纽约市医院实验室采用严重急性呼吸综合征冠状病毒2（新冠病毒病）分子检测样本合并方法的经验。
J Clin Pathol. 2022 Jan;75(1):65-67. doi: 10.1136/jclinpath-2020-207077. Epub 2021 Feb 15.
3
CRISPR-Based COVID-19 Smartphone Test in Development.基于CRISPR的新冠病毒智能手机检测正在研发中。
JAMA. 2021 Feb 9;325(6):522. doi: 10.1001/jama.2021.0493.
4
Critical paediatric COVID-19: varied presentations but good outcomes.儿童重症 COVID-19：表现多样但预后良好。
Arch Dis Child. 2021 Mar;106(3):e10. doi: 10.1136/archdischild-2020-319602. Epub 2020 Jun 29.
5
Evaluation of droplet digital PCR for quantification of SARS-CoV-2 Virus in discharged COVID-19 patients.采用液滴数字PCR技术对出院新冠患者的SARS-CoV-2病毒进行定量分析
Aging (Albany NY). 2020 Nov 1;12(21):20997-21003. doi: 10.18632/aging.104020.
6
Association Between Upper Respiratory Tract Viral Load, Comorbidities, Disease Severity, and Outcome of Patients With SARS-CoV-2 Infection.上呼吸道病毒载量、合并症、疾病严重程度与 SARS-CoV-2 感染患者结局的关系。
J Infect Dis. 2021 Apr 8;223(7):1132-1138. doi: 10.1093/infdis/jiaa804.
7
Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.比较两种 SARS-CoV-2 RNA 检测样本混合策略，以提高 COVID-19 高效筛查效率。
J Med Virol. 2021 May;93(5):2805-2809. doi: 10.1002/jmv.26632. Epub 2021 Mar 11.
8
Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.雅培ID NOW新型冠状病毒肺炎快速分子检测法与赛沛Xpert Xpress新型冠状病毒检测法在干燥鼻拭子中的比较。
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115208. doi: 10.1016/j.diagmicrobio.2020.115208. Epub 2020 Sep 16.
9
Parallel testing of 241 clinical nasopharyngeal swabs for the detection of SARS-CoV-2 virus on the Cepheid Xpert Xpress SARS-CoV-2 and the Roche cobas SARS-CoV-2 assays.使用赛沛Xpert Xpress SARS-CoV-2检测系统和罗氏cobas SARS-CoV-2检测方法对241份临床鼻咽拭子进行平行检测，以检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒。
Clin Chem Lab Med. 2020 Nov 19;59(2):e45-e48. doi: 10.1515/cclm-2020-1338.
10
Dynamics of Blood Viral Load Is Strongly Associated with Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) Patients: A Prospective Cohort Study.新冠肺炎（COVID-19）患者的血液病毒载量动力学与临床结局密切相关：一项前瞻性队列研究。
J Mol Diagn. 2021 Jan;23(1):10-18. doi: 10.1016/j.jmoldx.2020.10.007. Epub 2020 Oct 26.

引用本文的文献

1
Post-market surveillance of six COVID-19 point-of-care tests using pre-Omicron and Omicron SARS-CoV-2 variants.使用 Omicron 变异株之前和 Omicron 变异株对六种 COVID-19 即时检测进行上市后监测。
Microbiol Spectr. 2024 Jul 2;12(7):e0016324. doi: 10.1128/spectrum.00163-24. Epub 2024 May 17.
2
Relationship between the Viral Load in Patients with Different COVID-19 Severities and SARS-CoV-2 Variants.不同严重程度的新型冠状病毒肺炎患者病毒载量与严重急性呼吸综合征冠状病毒2变异株之间的关系
Microorganisms. 2024 Feb 20;12(3):428. doi: 10.3390/microorganisms12030428.
3
A Multiple-Center, Retrospective Study of Characteristics and Outcomes of Hospitalized COVID-19 Patients with Cardiovascular Disease in North Iran.

本文引用的文献

1
Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients.鼻咽病毒载量可预测COVID-19住院患者的低氧血症和疾病转归。
Crit Care. 2020 Sep 1;24(1):539. doi: 10.1186/s13054-020-03244-3.
2
SARS-CoV-2 viral load predicts COVID-19 mortality.严重急性呼吸综合征冠状病毒2型病毒载量可预测新冠肺炎死亡率。
Lancet Respir Med. 2020 Sep;8(9):e70. doi: 10.1016/S2213-2600(20)30354-4. Epub 2020 Aug 6.
3
Association of Initial Viral Load in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients with Outcome and Symptoms.
伊朗北部 COVID-19 合并心血管疾病住院患者特征和结局的多中心回顾性研究。
Ethiop J Health Sci. 2023 Jan;33(1):3-12. doi: 10.4314/ejhs.v33i1.2.
4
Anaesthetic Management of Pulmonary Metastasectomy in a Patient Infected with Novel Corona Virus SARS-CoV-2.新型冠状病毒 SARS-CoV-2 感染患者肺转移切除术的麻醉管理。
Sultan Qaboos Univ Med J. 2022 Nov;22(4):578-582. doi: 10.18295/squmj.9.2021.137. Epub 2022 Nov 7.
5
Laboratory Considerations for Reporting Cycle Threshold Value in COVID-19.新型冠状病毒肺炎循环阈值报告的实验室考量
EJIFCC. 2022 Aug 8;33(2):80-93. eCollection 2022 Aug.
6
Temporal trends in clinical characteristics and in-hospital mortality among patients with COVID-19 in Japan for waves 1, 2, and 3: A retrospective cohort study.日本 COVID-19 第 1、2 和 3 波患者的临床特征和住院死亡率的时间趋势：一项回顾性队列研究。
J Infect Chemother. 2022 Oct;28(10):1393-1401. doi: 10.1016/j.jiac.2022.06.013. Epub 2022 Jun 29.
7
Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR).与逆转录定量聚合酶链反应（RT-qPCR）弱阳性 SARS-CoV-2 诊断相关的因素。
Pathology. 2022 Aug;54(5):623-628. doi: 10.1016/j.pathol.2022.04.001. Epub 2022 Jun 29.
8
Laboratory Diagnosis for SARS-CoV-2 Infection.SARS-CoV-2 感染的实验室诊断。
Infect Dis Clin North Am. 2022 Jun;36(2):327-347. doi: 10.1016/j.idc.2022.02.002.
9
The Treatment of COVID-19 Purgatory Syndrome With Tocilizumab and Steroids.托珠单抗和类固醇治疗新型冠状病毒肺炎炼狱综合征
Cureus. 2022 Feb 25;14(2):e22614. doi: 10.7759/cureus.22614. eCollection 2022 Feb.
10
Management of hepatitis B virus reactivation due to treatment of COVID-19.因 COVID-19 治疗导致乙型肝炎病毒再激活的管理。
Hepatol Int. 2022 Apr;16(2):257-268. doi: 10.1007/s12072-022-10306-x. Epub 2022 Mar 2.
严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）患者初始病毒载量与结局和症状的关系。
Am J Pathol. 2020 Sep;190(9):1881-1887. doi: 10.1016/j.ajpath.2020.07.001. Epub 2020 Jul 3.
4
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study.2020 年 1 月至 3 月在中国浙江省感染 SARS-CoV-2 的患者的病毒载量动态和疾病严重程度：回顾性队列研究。
BMJ. 2020 Apr 21;369:m1443. doi: 10.1136/bmj.m1443.
5
Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China.中国武汉 COVID-19 患者疾病严重程度、无改善和死亡率的危险因素。
Clin Microbiol Infect. 2020 Jun;26(6):767-772. doi: 10.1016/j.cmi.2020.04.012. Epub 2020 Apr 15.
6
Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.在重症 2019 冠状病毒病患者中，可检测到的血清严重急性呼吸综合征冠状病毒 2 病毒载量（RNAemia）与显著升高的白细胞介素 6 水平密切相关。
Clin Infect Dis. 2020 Nov 5;71(8):1937-1942. doi: 10.1093/cid/ciaa449.
7
SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients.重症患者临床样本中的新冠病毒载量
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1435-1438. doi: 10.1164/rccm.202003-0572LE.
8
Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus 2: A Narrative Review.严重急性呼吸综合征相关冠状病毒 2 的诊断检测：叙述性综述。
Ann Intern Med. 2020 Jun 2;172(11):726-734. doi: 10.7326/M20-1301. Epub 2020 Apr 13.
9
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.2019 冠状病毒病（COVID-19）的重症监护管理：挑战与建议。
Lancet Respir Med. 2020 May;8(5):506-517. doi: 10.1016/S2213-2600(20)30161-2. Epub 2020 Apr 6.
10
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.COVID-19 肺炎患者进展风险预测：CALL 评分。
Clin Infect Dis. 2020 Sep 12;71(6):1393-1399. doi: 10.1093/cid/ciaa414.